Who Paid My Doc
Jeffrey Baker
Obstetrics & Gynecology Idaho Falls, ID Medical Doctor
NPI 1275603193 CMS profile 827321
187 E. 13Th St., Idaho Falls, ID 83404
General payments
$17,806
Research payments
$24,432
Ownership & investment interest
$0
Research they led as principal investigator
$36,071,146
Through program year 2025, Jeffrey Baker of Idaho Falls, ID is reported in the CMS Open Payments database as having received $17,806 across 68 general payments and $24,432 in research payments paid to them. Separately, studies naming them as principal investigator received $36,071,146 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
11 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,944 | 13 | |
| 2025 | Research | $11,348 | 3 | |
| 2024 | General | $3,385 | 18 | |
| 2024 | Research | $5,441 | 3 | |
| 2023 | General | $2,064 | 5 | |
| 2023 | Research | $4,443 | 2 | |
| 2022 | General | $617 | 2 | |
| 2022 | Research | $3,200 | 1 | |
| 2021 | General | $680 | 6 | |
| 2020 | General | $5,546 | 7 | |
| 2019 | General | $2,569 | 17 |
Beside peers
- Jeffrey Baker
- Obstetrics & Gynecology median
- Middle half of Obstetrics & Gynecology
- National median
In program year 2025, general payments to Jeffrey Baker were reported at $2,944. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.
Show as a table
| Year | Jeffrey Baker | Obstetrics & Gynecology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,569 | $172 | $62–$391 | $163 |
| 2020 | $5,546 | $94 | $36–$222 | $114 |
| 2021 | $680 | $136 | $42–$369 | $132 |
| 2022 | $617 | $160 | $50–$433 | $149 |
| 2023 | $2,064 | $169 | $56–$423 | $160 |
| 2024 | $3,385 | $152 | $50–$371 | $164 |
| 2025 | $2,944 | $158 | $51–$401 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
228
Drug cost
$5,394
Branded share of claims
28.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Progesterone Progesterone, Micronized | Brand | 65 | $3,676 | |
| Levothyroxine Sodium | Generic | 84 | $1,257 | |
| Estradiol | Generic | 20 | $274 | |
| Atorvastatin Calcium | Generic | 16 | $76 | |
| Lisinopril | Generic | 11 | $53 | |
| Tamsulosin Hcl | Generic | 16 | $41 | |
| Metformin Hcl | Generic | 16 | $16 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 15 billing codesPaid by Medicare
$10,807
Medicare patients
81
Services billed
152
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 47% | |
| High blood pressure | 44% | |
| Diabetes | 19% | |
| Chronic kidney disease | 16% | |
| Depression | 16% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
77 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Obstetrics & Gynecology in Idaho
Ty Erickson
Obstetrics & Gynecology · Idaho Falls, ID
Kim Cox
Obstetrics & Gynecology · Pocatello, ID
Kelly Siudzinski
Obstetrics & Gynecology · Meridian, ID
Michael Cannon
Obstetrics & Gynecology · Twin Falls, ID
Glenn Leavitt
Obstetrics & Gynecology · Idaho Falls, ID
Guillermo Guzman Trevino
Obstetrics & Gynecology · Nampa, ID
Related records
Obstetrics & Gynecology in Idaho
Practitioners in the same specialty and state, ranked by reported value.
All Obstetrics & Gynecology
Everyone recorded under this specialty, nationwide.
Doctors in Idaho
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.